Supplement industry news and updates – June 2024

10 Euro ingredient innovations spotted at Vitafoods 2024 – slideshow

From probiotics to emotional health, click through 10 pieces of market intel for you straight from Geneva, Switzerland, where 20,000 attendees and 1,000 exhibitors convened for Europe’s biggest and best supplement ingredients show. Catch up on the latest mushroom research and learn what’s fueling fungi innovation.

VMS Insights from SPINS: The top trending ‘holy grail’ supplements – article

Whether you’re a brand doing strategic planning for 2025 launches, or you’re an ingredient provider or contract manufacturer, forecasting market demand can be tough. See the must-haves poised for optimum growth. Read more here.

New numbers clarify long-term sales forecast – article

Are we there yet? Look into what new NBJ Supplement Business Report 2024 data spells out in terms of the “new normal” in consumer beliefs and behavior: whether we’ve reached it and what might come next. Learn why recent mood, mental health and sports supplement sales may offer solid clues. Read more here.

U.S. Pharmacopeia’s (USP) new policy supports mandatory product listing – article

U.S. Pharmacopeia (USP) has come down strongly on the side of mandatory product listing as part of a DSHEA overhaul in a new policy document released by the organization recently. The supplement industry’s trade groups are split over mandatory product listing, something FDA is asking Congress to require in its fiscal year 2025 budget request. Learn about the objectives and where this may be heading. Read more here.

NY judge strikes down most of CRN’s case against new law – article

A judge has dismissed all claims except for a First Amendment cause of action in CRN’s lawsuit that aims to overturn a law restricting the sale of some supplements in the state of New York. Minors now cannot buy weight management or muscle-building supplements in the state because of a concern from the legislature that they may exacerbate eating disorders. Read more here.

CBD industry rallies against Farm Bill amendment that could gut industry – article

According to the U.S. Hemp Roundtable, the amendment, which would alter definitions in the Farm Bill, would ban most ingestible CBD products. Some stakeholders claim it may be an end run by marijuana companies to squelch competition from CBD firms. Others say the ban would negate much of the sector’s science. Read more here.

Proprietary blends: Just fairy dust subterfuge? – article

Dig into the use of proprietary blends, which began as a way to protect intellectual property but now many feel is just fuel for “marketing science,” for poor-quality or even fraudulent formulas. Read how the science can be fishy and the math certainly doesn’t check out when calculating efficacious dosage. Read more here.